Am J Transplant, Volume 5, Suppl 3 Archives - Page 146 of 170 - ATC Abstracts

2015 American Transplant Congress
Delayed Tacrolimus (TAC) to Rapamycin (RAPA) Conversion in Renal Transplant Recipients With DGF/SGF
A. Haririan,¹ D. Klassen,¹ M. Keshtkar,¹ C. Drachenberg,² T. Dowling,³ E. Ramos,¹ R. Ugarte,¹ C. Cangro,¹ M. Weir.¹
¹Medicine, University of Maryland, Baltimore, MD; ²Pathology, University of Maryland, Baltimore, MD; ³Pharmacy, University of Maryland, Baltimore, MD.
The role of conversion from TAC to RAPA early after kidney transplantation in patients with DGF/SGF in improving graft function and delaying chronic allograft dysfunction…
2015 American Transplant Congress
Evaluation of Serum sCD30 as a Predictor in Kidney Transplant Recipients
X.-Z. Wang, W.-J. Xue, X.-H. Tian, J. Zheng, P.-X. Tian, X.-M. Ding.
Kidney Transplantation, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Objective To explore the significance of serum CD30 in predicting acute rejection and pneumonia in kidney transplant recipients. Methods A total of 106 kidney transplant…
2015 American Transplant Congress
Advanced Imaging Modalities for Hepatocellular Carcinoma: Is MRI With Eovist Really Better?
M. Chen, H. Reich, M. Uffenheimer, Y. Nasseri, A. Annamalai.
Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
Introduction: Hepatocellular cancer (HCC) is a common indication for transplantation. Eovist (gadolinium-EOB-DTPA), compared to conventional gadolinium-enhanced MRI (MRI-Gd) or triple-phase contrast-enhanced computed tomography (CT), is…
2015 American Transplant Congress
Liver Transplantation for Hepatocellular Carcinoma inside Milan Criteria: Lower Recurrence in Patients With Hepatitis C Infection
W. Palmer, D. Lee, J. Burns, A. Keaveny, J. Melendez, J. Nguyen, T. Patel, S. Pungpapong, B. Rosser, R. Paz-Fumagalli, R. Nakhleh, K. Musto, D. Harnois.
Mayo Clinic, Jacksonville, FL.
Purpose: Hepatitis C infection (HCV) related-cirrhosis can lead to hepatocellular carcinoma (HCC). Liver transplantation (LT) is the optimal treatment for selected patients with HCC, providing…
2015 American Transplant Congress
Pediatric Liver Transplantation from Living Donors in Cali – Colombia
L. Caicedo, V. Botero, J. Villegas, O. Serrano, M. Duque, M. Valderrama, E. Manzi, M. Agudelo, G. Echeverri.
Transplant Unit, Fundacion Valle del Lili, Cali, Valle del Cauca, Colombia.
Introduction. Starting a pediatric liver transplant program in a developing country, is a great challenge, due to technical difficulties and increased morbidity and mortality, and…
2015 American Transplant Congress
Association of Transplant Volume and Survival in Pediatric Kidney Transplants
W. Cherikh,¹ A. Wilk,¹ C. Flavin,¹ E. Brewer.²
¹United Network for Organ Sharing, Richmond, VA; ²Baylor Coll Med & Texas Children's Hosp., Houston, TX.
Background. Center specific volume has been shown to correlate with outcomes for many procedures in the adult population. The current analysis was conducted to determine…
2015 American Transplant Congress
Successful Consolidation of Two Kidney/Pancreas Transplant Programs
D. Morgan, A. Tietjen, S. Mulgoankar.
Renal & Pancreas Transplant, Barnabas Health, Livingston.
The decision to consolidate two kidney/pancreas transplant programs within the same healthcare system and within a 10 mile radius, was a pro-active approach in an…
2015 American Transplant Congress
The Correlation Between Donor Specific Antibodies and Heart Transplant Rejection
R. Bedard,¹ P. Jindra,² M. Manson,¹ M. Moaddab,¹ H. Mallidi,³ W. Etheridge,¹ A. Civitello,³ R. Kerman.²
¹CHI St. Luke's Health - Baylor St. Luke's Medical Center, Houston, TX; ²Immune Evaluation Laboratory, Baylor College of Medicine, Houston, TX; ³Texas Heart Institute, Baylor College of Medicine, Houston, TX.
The presence of donor specific HLA antibodies (DSA) has been shown to be detrimental to heart transplant (HTx) survival. Virtual crossmatching (VXM) offers a rapid…
2015 American Transplant Congress
The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review
M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3
¹Medicine, Division of Infectious Diseases, University Health Network, Toronto, On, Canada; ²Pediatrics, Division of Infectious Diseases, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia; ³Multi-Organ Transplant Unit, University Health Network, Toronto, ON, Canada.
Background The role of antiviral prophylaxis in EBV seronegative solid organ transplant recipients receiving organs from seropositive donors for prevention of PTLD remains controversial. We…
2015 American Transplant Congress
Pre-Trasplant Perfusion With Mesenchymal Stromal Cells of Renal Graft Prevents Ischemia Injury Upregulating Gene Involved in Energy Saving
V. Corradetti,¹ S. Milanesi,¹ E. Pattonieri,¹ C. Rocca,¹ T. Valsania,¹ M. Gregorini,¹ L. De Cecco,² I. Benzoni,³ C. Bianco,³ M. Avanzini,⁴ M. Maestri,³ P. Esposito,¹ T. Rampino,¹ A. Dal Canton.
¹Unit of Nephrology, Dialysis and Transplantation, IRCCS Fondazione Policlinico San Matteo And University of Pavia, Pavia, Italy; ²Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy; ³Unit of General Surgery, IRCCS Fondazione Policlinico San Matteo And University of Pavia, Pavia, Italy; ⁴Cell Factory Pediatric Oncohaematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Background. Kidney ischemia from Donation after Circulatory Death shifts cells to anaerobic metabolism. Mesenchymal Stromal Cells (MSC) have immunomodulatory properties that are mediated by soluble…